Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Dec-22 5:00 PM View:  | Design Therapeutics, Inc. (DSGN) | 20-Dec-22 | Purchase | 6,300 | $8.38 | $52,762.50 | 5% 126.32K to 132.62K | |
| 21-Dec-22 5:00 PM View: | Design Therapeutics, Inc. (DSGN) | 19-Dec-22 | Private Purchase | 1,150 | $8.47 | $9,740.50 | < 1% 125.17K to 126.32K | |
| 22-May-20 6:13 PM View: | Access Pharmaceuticals Inc. (ABEO) | 20-May-20 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 15-May-18 12:40 PM View: | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,106 | -- | -- | (100%) 1.11K to 0 | |
| 30-Mar-18 5:55 PM View: | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,106 | -- | -- | 100% 0 to 1.11K | |
| 22-Dec-14 8:07 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Dec-14 | Payment of Exercise | 19,204 | $16.99 | $326,276.00 | (6%) 348.9K to 329.7K | < 1% |
| 22-Dec-14 8:07 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Dec-14 | Option Exercise | 32,291 | $2.59 | $83,633.70 | 10% 316.61K to 348.9K | |
| 22-Dec-14 8:07 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Dec-14 | Market Option Sale (Planned) | 15,505 | $16.93 | $262,500.00 | (5%) 329.7K to 314.19K | < 1% |
| 12-Nov-14 10:00 PM View: | Avanir Pharmaceuticals (AVNR) | 10-Nov-14 | Grant | 94,056 | -- | -- | 19% 504.34K to 598.39K | |
| 24-Oct-14 8:48 PM View: | Avanir Pharmaceuticals (AVNR) | 24-Oct-14 | Market Sale (Planned) | 8,426 | $11.80 | $99,426.80 | (4%) 230.98K to 222.55K | (< 1%) |
| 30-May-14 8:00 PM View: | Avanir Pharmaceuticals (AVNR) | 28-May-14 | Market Sale | 13,547 | $5.18 | $70,173.50 | (6%) 244.53K to 230.98K | (120%) |
| 14-Feb-14 7:53 PM View: | Avanir Pharmaceuticals (AVNR) | 12-Feb-14 | Grant | 123,750 | -- | -- | 112% 110.23K to 233.98K | |
| 20-Dec-13 5:32 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Dec-13 | Market Sale (Planned) | 5,970 | $2.63 | $15,713.00 | (5%) 116.2K to 110.23K | (333%) |
| 19-Sep-13 8:50 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Sep-13 | Option Exercise | 21,094 | $1.85 | $39,023.90 | 18% 116.2K to 137.29K | |
| 19-Sep-13 8:50 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Sep-13 | Market Option Sale (Planned) | 21,094 | $4.22 | $88,968.20 | (15%) 137.29K to 116.2K | (170%) |
| 19-Dec-12 4:39 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Dec-12 | Grant | 84,000 | -- | -- | 261% 32.2K to 116.2K | |
| 14-May-12 11:14 AM View: | Avanir Pharmaceuticals (AVNR) | 10-May-12 | Market Purchase | 2,700 | $2.96 | $7,992.00 | 9% 29.5K to 32.2K | 283% |
| 16-Dec-11 8:40 PM View: | Avanir Pharmaceuticals (AVNR) | 15-Dec-11 | Grant | 29,500 | -- | -- | 100% 0 to 29.5K |